News
This idea changed over the years and, since the 1990s, addiction has been described as a chronic brain disease, particularly in the biomedical and neuroscience literature.
For example, stress causes physiological changes; certain physiological changes (e.g. pain) cause stress. Finally, the BPS model also incorporates social factors in its conceptualization of illness.
Entheon Biomedical CEO Timothy Ko On The Potential Of Psychedelics In Addiction Treatment - Benzinga
Among the biggest challenges faced by the psychedelics industry is the stigma that surrounds it. "The anti-drug marketing of the past decades was highly effective, and so now when psychedelics are ...
JACKSON CENTER, PA / ACCESSWIRE / July 30, 2019 / Premier Biomedical, Inc. (OTCQB: BIEI) announced today the signing of an agreement forming a joint venture with New Earth Development Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results